From Sequence to Information
Total Page:16
File Type:pdf, Size:1020Kb
Load more
Recommended publications
-
Involvement of REST Corepressor 3 in Prognosis of Human Hepatitis B
Acta Pharmacologica Sinica (2011) 32: 1019–1024 npg © 2011 CPS and SIMM All rights reserved 1671-4083/11 $32.00 www.nature.com/aps Original Article Involvement of REST corepressor 3 in prognosis of human hepatitis B Ji-hua XUE, Min ZHENG, Xiao-wei XU, Shan-shan WU, Zhi CHEN, Feng CHEN* State Key Laboratory for Diagnosis and Treatment of Infectious Diseases, the First Affiliated Hospital, School of Medicine, Zhejiang University, Hangzhou 310003, China Aim: To examine the potential correlation between serum REST corepressor 3 (RCOR3) level and the outcome of patients with hepa- titis B. Methods: Concanavalin A (ConA)-induced mouse hepatitis model was used. The mRNA level of RCOR3 in mouse liver was measured using GeneChip array and real-time PCR. One hundred seventy-seven patients with hepatitis B and 34 healthy individuals were catego- rized into six groups including mild chronic hepatitis, moderate chronic hepatitis B, severe hepatitis B (SHB), cirrhosis, hepatocellular carcinoma (HCC) and healthy control. Serum levels of human RCOR3 were measured using ELISA. Results: In the mouse hepatitis model, the mRNA level of RCOR3 in liver was reduced early after exposure to ConA, then increased after 6 h of exposure. There was no significant difference in the serum RCOR3 level between the mild chronic hepatitis B and the con- trol groups. The serum RCOR3 level was significantly increased in the moderate chronic hepatitis B group, but significantly reduced in SHB, cirrhosis and HCC groups, as compared with the control group. Moreover, the serum RCOR3 levels in SHB, cirrhosis and liver cancer patients were significantly lower than those in the patients with moderate chronic hepatitis B and with mild chronic hepatitis B. -
Silencer Elements Controlling the B29 (Ig) Promoter Are Neither Promoter- Nor Cell-Type-Specific
Proc. Natl. Acad. Sci. USA Vol. 94, pp. 12314–12319, November 1997 Biochemistry Silencer elements controlling the B29 (Igb) promoter are neither promoter- nor cell-type-specific CINDY SUE MALONE*, SIDNE A. OMORI*†, AND RANDOLPH WALL*‡ *Molecular Biology Institute and Department of Microbiology and Immunology, University of California, Los Angeles, School of Medicine, Los Angeles, CA 90095 Communicated by David S. Eisenberg, University of California, Los Angeles, CA, July 11, 1997 (received for review May 9, 1997) ABSTRACT The murine B29 (Igb) promoter is B cell combinatorial activities of this cassette of different transcrip- specific and contains essential SP1, ETS, OCT, and Ikaros tion factors (11, 20). motifs. Flanking 5* DNA sequences inhibit B29 promoter The current study focuses on the B29 regulatory region 59 of activity, suggesting this region contains silencer elements. the murine minimal B29 promoter. Deletion analyses of the Two adjacent 5* DNA segments repress transcription by the B29 gene 59 flanking region revealed two adjacent regions with murine B29 promoter in a position- and orientation- significantly lower transcriptional activity than the minimal independent manner, analogous to known silencers. Both promoter, suggesting the presence of silencer elements. Si- these 5* segments also inhibit transcription by several heter- lencers are functionally defined cis-acting regulatory DNA ologous promoters in B cells, including mb-1, c-fos, and human elements that down-regulate gene transcription. They gener- B29. These 5* segments also inhibit transcription by the c-fos ally exhibit activity in either orientation, may be either posi- promoter in T cells suggesting they are not B cell-specific tion-dependent or -independent, and may or may not affect elements. -
Robijn Bruinsma
Opportunities for Theory in Biological Physics. 1) Chromosome Control. 2) The Polyglutamine Problem. 3) Transcription Initiation Complex. 4) Ribosomal Proofreading. 5) Focal Adhesion Sites. *DNA/DNA interaction: Aqueous electrostatics beyond mean-field theory. (Oosawa) *DNA/nucleosome interaction: electrostatic attraction versus bending stiffness. (Manning) *Micromechanics (M.Wang) Nucleus: 23 chromosomes (1m DNA in micron-sized nucleus) Gene regulation by compaction. “Chromosome painting”: 3D-FISH Statics: 3-D Reconstruction of Nucleus. DNA-DNA mean spacing: 30-40 Angstrom. Close-packing is close (Cremer) Expanded Chromosome Condensed Loop (active genes) inactive genes Decondensed, active genes Inter-chromatin Compartment Active gene: on surface. Late replicating gene Nucleus is fully accessible to protein transport. 3-D Fish: Chromosome Dynamics (20 minute intervals) Chromosomal “Diffusion” Chromosomal Volume and Surface Area vs time. Statics: How is the “open” architecture of the nucleus maintained and controlled under the osmotic pressure of de-condensed, active DNA sections. Equation of State of DNA bundles is known. Dynamics: Chromosome dynamics driven by DNA condensation/de-conden- sation events triggered by local gene expression:”gene noise”. *Can we deduce temporal and spatial correlation functions for gene noise from the motion of the chromosomes by fluctuation analysis and relate it to gene activity? *Chromosome “micro-rheology”? The Polyglutamine Problem Nine neuro-degenerative diseases are associated with (CAG)N triplet repeats: Huntingdon’s, spinal dystrophy, ataxia …. CAG is the code for the amino-acid glutamine. C. Elegans worm GFP (CAG)N N=19 Homogeneous N=82: Toxic Aggregates Impaired motility Proteosome action N=82 (x 40) inhibited. Aggregates: N > 35-40 In vitro polyglutamine homopolymer aggregation (N=37) Aggregation Kinetics (Wetzel): Chen, Songming et al. -
Is Glyceraldehyde-3-Phosphate Dehydrogenase a Central Redox Mediator?
1 Is glyceraldehyde-3-phosphate dehydrogenase a central redox mediator? 2 Grace Russell, David Veal, John T. Hancock* 3 Department of Applied Sciences, University of the West of England, Bristol, 4 UK. 5 *Correspondence: 6 Prof. John T. Hancock 7 Faculty of Health and Applied Sciences, 8 University of the West of England, Bristol, BS16 1QY, UK. 9 [email protected] 10 11 SHORT TITLE | Redox and GAPDH 12 13 ABSTRACT 14 D-Glyceraldehyde-3-phosphate dehydrogenase (GAPDH) is an immensely important 15 enzyme carrying out a vital step in glycolysis and is found in all living organisms. 16 Although there are several isoforms identified in many species, it is now recognized 17 that cytosolic GAPDH has numerous moonlighting roles and is found in a variety of 18 intracellular locations, but also is associated with external membranes and the 19 extracellular environment. The switch of GAPDH function, from what would be 20 considered as its main metabolic role, to its alternate activities, is often under the 21 influence of redox active compounds. Reactive oxygen species (ROS), such as 22 hydrogen peroxide, along with reactive nitrogen species (RNS), such as nitric oxide, 23 are produced by a variety of mechanisms in cells, including from metabolic 24 processes, with their accumulation in cells being dramatically increased under stress 25 conditions. Overall, such reactive compounds contribute to the redox signaling of the 26 cell. Commonly redox signaling leads to post-translational modification of proteins, 27 often on the thiol groups of cysteine residues. In GAPDH the active site cysteine can 28 be modified in a variety of ways, but of pertinence, can be altered by both ROS and 29 RNS, as well as hydrogen sulfide and glutathione. -
UNIT 6 from DNA to Protein: Gene Expression PART 2 Hillis Textbook
UNIT 6 PART 3 *REGULATION USING OPERONS* Hillis Textbook, CH 11 REVIEW: Signals that Start and Stop Transcription and Translation BUT, HOW DO CELLS CONTROL WHICH GENES ARE EXPRESSED AND WHEN? First of all, There is a difference between regulation in a prokaryote and a eukaryote…. OPERONS - PROKARYOTES Prokaryotes conserve energy by making proteins only when needed. The most efficient gene regulation is at the level of transcription. A gene cluster with a single promoter is an operon. An operator is a short stretch of DNA near the promoter that controls transcription of the structural genes. 1. Inducible operon—turned off unless needed In inducible systems—a metabolic substrate (inducer) interacts with a regulatory protein (repressor); the repressor cannot bind and allows transcription. Usually control CATABOLIC REACTIONS 2. Repressible operon—turned on unless not needed In repressible systems—a metabolic product (co-repressor) binds to regulatory protein, which then binds to the operator and blocks transcription. Usually control ANABOLIC REACTIONS. LAC OPERON - INDUCIBLE A compound that induces protein synthesis is an inducer. When the enzymes are induced, metabolism will take place. LAC OPERON – INDUCIBLE E. coli must adapt quickly to supply of food (lactose is a dissacharide example) Uptake and metabolism of lactose involves three important -galactoside enzymes -galactoside is a type of glycosidic bond between monosaccharides… if this is present, LACTOSE is present. If E. coli is grown with glucose but no lactose present, no enzymes for lactose conversion are produced. If lactose is predominant and glucose is low, E. coli synthesizes all three enzymes. If lactose is removed, synthesis stops. -
The Neuron-Restrictive Silencer Element: a Dual Enhancer͞silencer Crucial for Patterned Expression of a Nicotinic Receptor Gene in the Brain
Proc. Natl. Acad. Sci. USA Vol. 94, pp. 5906–5911, May 1997 Neurobiology The neuron-restrictive silencer element: A dual enhancerysilencer crucial for patterned expression of a nicotinic receptor gene in the brain ALAIN BESSIS*, NICOLAS CHAMPTIAUX,LAURENT CHATELIN, AND JEAN-PIERRE CHANGEUX† Neurobiologie Mole´culaire,UA CNRS D1284, De´partementdes Biotechnologies, Institut Pasteur 25y28 rue du Dr Roux, 75724 Paris Cedex 15 Contributed by Jean-Pierre Changeux, March 24, 1997 ABSTRACT The neuron-restrictive silencer element transcriptional repressing activity on promoters that carry the (NRSE) has been identified in several neuronal genes and NRSE sequence (15, 21, 23). confers neuron specificity by silencing transcription in non- In this work, we have analyzed the function of NRSE in the neuronal cells. NRSE is present in the promoter of the promoter of the mouse gene encoding the nAChR b2-subunit neuronal nicotinic acetylcholine receptor b2-subunit gene as well as the importance of its location within the promoter. that determines its neuron-specific expression in the nervous In transgenic mice, we show that upon mutation of NRSE, the system. Using transgenic mice, we show that NRSE may either pattern of expression of the b2-subunit gene promoter dra- silence or enhance transcription depending on the cellular matically changes but remains restricted to the nervous system. context within the nervous system. In vitro in neuronal cells, We confirm that NRSE in vitro can behave either as an NRSE activates transcription of synthetic promoters when enhancer or as a silencer depending both on the primary located downstream in the 5* untranslated region, or at less structure of the promoter and the type of cell line. -
Multifunctional Proteins: Involvement in Human Diseases and Targets of Current Drugs
The Protein Journal (2018) 37:444–453 https://doi.org/10.1007/s10930-018-9790-x Multifunctional Proteins: Involvement in Human Diseases and Targets of Current Drugs Luis Franco‑Serrano1 · Mario Huerta1 · Sergio Hernández1 · Juan Cedano2 · JosepAntoni Perez‑Pons1 · Jaume Piñol1 · Angel Mozo‑Villarias3 · Isaac Amela1 · Enrique Querol1 Published online: 19 August 2018 © The Author(s) 2018 Abstract Multifunctionality or multitasking is the capability of some proteins to execute two or more biochemical functions. The objective of this work is to explore the relationship between multifunctional proteins, human diseases and drug targeting. The analysis of the proportion of multitasking proteins from the MultitaskProtDB-II database shows that 78% of the proteins analyzed are involved in human diseases. This percentage is much higher than the 17.9% found in human proteins in general. A similar analysis using drug target databases shows that 48% of these analyzed human multitasking proteins are targets of current drugs, while only 9.8% of the human proteins present in UniProt are specified as drug targets. In almost 50% of these proteins, both the canonical and moonlighting functions are related to the molecular basis of the disease. A procedure to identify multifunctional proteins from disease databases and a method to structurally map the canonical and moonlighting functions of the protein have also been proposed here. Both of the previous percentages suggest that multitasking is not a rare phenomenon in proteins causing human diseases, and that their detailed study might explain some collateral drug effects. Keywords Multitasking proteins · Human diseases · Protein function · Drug targets 1 Introduction decades ago when they demonstrated that lens crystallins and some metabolic enzymes were the same protein, even The aim of this work was to analyse the link between moon- doing a completely different function and in distinct cel- lighting proteins and human diseases, as well as between lular localizations [1]. -
Transcription in Archaea
Proc. Natl. Acad. Sci. USA Vol. 96, pp. 8545–8550, July 1999 Evolution Transcription in Archaea NIKOS C. KYRPIDES* AND CHRISTOS A. OUZOUNIS†‡ *Department of Microbiology, University of Illinois at Urbana-Champaign, B103 Chemistry and Life Sciences, MC 110, 407 South Goodwin Avenue, Urbana, IL 61801; and †Computational Genomics Group, Research Programme, The European Bioinformatics Institute, European Molecular Biology Laboratory, Cambridge Outstation, Wellcome Trust Genome Campus, Cambridge CB10 1SD, United Kingdom Edited by Norman R. Pace, University of California, Berkeley, CA, and approved May 11, 1999 (received for review December 21, 1998) ABSTRACT Using the sequences of all the known transcrip- enzyme was found to have a complexity similar to that of the tion-associated proteins from Bacteria and Eucarya (a total of Eucarya (consisting of up to 15 components) (17). Subsequently, 4,147), we have identified their homologous counterparts in the the sequence similarity between the large (universal) subunits of four complete archaeal genomes. Through extensive sequence archaeal and eukaryotic polymerases was demonstrated (18). comparisons, we establish the presence of 280 predicted tran- This discovery was followed by the first unambiguous identifica- scription factors or transcription-associated proteins in the four tion of transcription factor TFIIB in an archaeon, Pyrococcus archaeal genomes, of which 168 have homologs only in Bacteria, woesei (19). Since then, we have witnessed a growing body of 51 have homologs only in Eucarya, and the remaining 61 have evidence confirming the presence of key eukaryotic-type tran- homologs in both phylogenetic domains. Although bacterial and scription initiation factors in Archaea (5, 20). Therefore, the eukaryotic transcription have very few factors in common, each prevailing view has become that Archaea and Eucarya share a exclusively shares a significantly greater number with the Ar- transcription machinery that is very different from that of Bac- chaea, especially the Bacteria. -
Structural Biology of Moonlighting — Lessons from Antibodies
Structural Biology of Moonlighting — Lessons from Antibodies Andrew C.R. Martin∗ Institute of Structural and Molecular Biology, Division of Biosciences, University College London, Gower Street, London WC1E 6BT September 29, 2014 Keywords: protein structure; complementarity determining regions; evolution Abstract Protein moonlighting is the property of a number of proteins to have more than one function. However, the definition of moonlighting is somewhat imprecise with dif- ferent interpretations of the phenomenon. True moonlighting occurs when an individ- ual evolutionary protein domain has one well-accepted roleˆ and a secondary unrelated function. The ‘function’ of a protein domain can be defined at different levels. For example, while the function of an antibody variable fragment (Fv) could be described as ‘bind- ing’; a more detailed definition would also specify the molecule to which the Fv region binds. Using this detailed definition, antibodies as a family are consummate moon- lighters. However, individual antibodies do not moonlight — the multiple functions they exhibit (first binding a molecule and second triggering the immune response) are encoded in different domains and, in any case, are related in the sense that they are both part of what an antibody needs to do. Nonetheless, antibodies provide interesting lessons on the ability of proteins to evolve binding functions. Remarkably-similar an- tibody sequences can bind completely different antigens, suggesting that evolving the ability to bind a protein can result from very subtle sequence changes. 1 Introduction The traditional dogma of biology has been that DNA is copied into RNA which encodes a protein with a single function. Over the last 10–15 years, this dogma has been chal- lenged in a number of ways. -
Identification of Potential Target Genes for the Neuron-Restrictive Silencer Factor CHRISTOPHER J
Proc. Natl. Acad. Sci. USA Vol. 93, pp. 9881-9886, September 1996 Neurobiology Identification of potential target genes for the neuron-restrictive silencer factor CHRISTOPHER J. SCHOENHERR*t, ALICE J. PAQUETTE*, AND DAVID J. ANDERSON*0§ *Division of Biology 216-76 and tHoward Hughes Medical Institute, California Institute of Technology, Pasadena, CA 91125 Communicated by Melvin I. Simon, California Institute of Technology, Pasadena, CA, June 6, 1996 (received for review March 13, 1996) ABSTRACT The neuron-restrictive silencer factor to most positive regulators of neuronal genes, NRSF activity, (NRSF) represses transcription of several neuronal genes in protein, and mRNA are not present in the majority ofneuronal nonneuronal cells by binding to a 21-bp element called the cells but are instead found in most nonneuronal cell types (18, neuron-restrictive silencer element (NRSE). We have per- 19, 21, 22). Thus, NRSF appears to prevent expression of formed data base searches with a composite NRSE to identify certain neuronal genes in nonneuronal cells. In addition, additional candidate NRSF target genes. Twenty-two more NRSF mRNA is expressed in undifferentiated neural precur- genes, 17 of which are expressed mainly in neurons, were sors (21, 22), suggesting that it may prevent precocious ex- found to contain NRSE-like sequences. Many ofthese putative pression of the neuronal phenotype during neurogenesis. NRSEs bound NRSF in vitro and repressed transcription in A further understanding of NRSF function would be aided vivo. Most of the neuronal genes identified contribute to the by the identification of additional target genes. In this report, basic structural or functional properties of neurons. -
Identification and Characterization of Moonlighting Long Non-Coding
bioRxiv preprint doi: https://doi.org/10.1101/261511; this version posted February 7, 2018. The copyright holder for this preprint (which was not certified by peer review) is the author/funder. All rights reserved. No reuse allowed without permission. Identification and characterization of moonlighting long non- coding RNAs based on RNA and protein interactome Lixin Cheng* and Kwong-Sak Leung* Department of Computer Science and Engineering, The Chinese University of Hong Kong, Shatin, New Territories, Hong Kong * Correspondence: [email protected] or [email protected] Abstract Moonlighting proteins are a class of proteins having multiple distinct functions, which play essential roles in a variety of cellular and enzymatic functioning systems. Although there have long been calls for computational algorithms for the identification of moonlighting proteins, research on approaches to identify moonlighting long non-coding RNAs (lncRNAs) has never been undertaken. Here, we introduce a methodology, MoonFinder, for the identification of moonlighting lncRNAs. MoonFinder is a statistical algorithm identifying moonlighting lncRNAs without a priori knowledge through the integration of protein interactome, RNA-protein interactions, and functional annotation of proteins. We identify 155 moonlighting lncRNA candidates and uncover that they are a distinct class of lncRNAs characterized by specific sequence and cellular localization features. The non-coding genes that transcript moonlighting lncRNAs tend to have shorter but more exons and the moonlighting lncRNAs have a localization tendency of residing in the cytoplasmic compartment in comparison with the nuclear compartment. Moreover, moonlighting lncRNAs and moonlighting proteins are rather mutually exclusive in terms of both their direct interactions and interacting partners. -
Structural Biology of Moonlighting: Lessons from Antibodies
Structural Biology of Moonlighting: Lessons from Antibodies Andrew C.R. Martin∗ Institute of Structural and Molecular Biology, Division of Biosciences, University College London, Gower Street, London WC1E 6BT August 2014 The Final Version of this paper is available at http://www.biochemsoctrans.org/content/42/6/1704.long Keywords: protein structure; complementarity determining regions; evolution Abstract Protein moonlighting is the property of a number of proteins to have more than one function. However, the definition of moonlighting is somewhat imprecise with dif- ferent interpretations of the phenomenon. True moonlighting occurs when an individ- ual evolutionary protein domain has one well-accepted roleˆ and a secondary unrelated function. The ‘function’ of a protein domain can be defined at different levels. For example, while the function of an antibody variable fragment (Fv) could be described as ‘bind- ing’; a more detailed definition would also specify the molecule to which the Fv region binds. Using this detailed definition, antibodies as a family are consummate moon- lighters. However, individual antibodies do not moonlight — the multiple functions they exhibit (first binding a molecule and second triggering the immune response) are encoded in different domains and, in any case, are related in the sense that they are both part of what an antibody needs to do. Nonetheless, antibodies provide interesting lessons on the ability of proteins to evolve binding functions. Remarkably-similar an- tibody sequences can bind completely different antigens, suggesting that evolving the ability to bind a protein can result from very subtle sequence changes. 1 Introduction The traditional dogma of biology has been that DNA is copied into RNA which encodes a protein with a single function.